Diversity & Clinical Trials: Access & Trust
Presented by Johnson & Johnson Innovation – JLABS and Newlab—a new limited event series focused on the topic of diversity, equity, and inclusion (DEI) in healthcare and clinical trials.
Join us on June 23rd at 12:00PM ET for part one of Diversity & Clinical Trials, Access & Trust. Our panel of speakers will investigate how recurring challenges in patient access to clinical trials affect study design, recruitment & retention, and diversity in data sets. What efforts should trial stakeholders explore to build trust and encourage buy-in into the trial process amongst diverse communities that are continually underrepresented?
- Kimberly Tableman — CEO, Medicine X
Featuring special guests:
- Ramona Burress — Associate Director, Diversity & Inclusion in Clinical Trials, The Janssen Pharmaceutical Companies of Johnson & Johnson
- Eric Roberts — Vice President, Trial Diversity & Inclusion, Real Chemistry
- Sophia Goodison —Director, Oncology, Safety Evaluation and Risk Management (SERM) Scientist, GSK